Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.76 USD | +3.53% | +10.00% | -1.77% |
Business Summary
Number of employees: 91
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Specialty Pharmaceutical Products
100.0
%
| 42 | 100.0 % | 40 | 100.0 % | -5.85% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
97.2
%
| 41 | 96.4 % | 38 | 97.2 % | -5.08% |
Non-United States
2.8
%
| 2 | 3.6 % | 1 | 2.8 % | -26.67% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
A. Kazimi
CEO | Chief Executive Officer | 65 | 99-01-06 |
John Hamm
DFI | Director of Finance/CFO | 67 | 18-12-31 |
James Herman
CMP | Compliance Officer | 67 | 02-12-31 |
Director/Board Member | 72 | 99-01-05 | |
Shayla Simpson
IRC | Investor Relations Contact | - | - |
Chris Bitterman
SAM | Sales & Marketing | 58 | 17-12-31 |
Kenny Acevedo
SAM | Sales & Marketing | - | 10-12-31 |
Adam Mostafa
PRN | Corporate Officer/Principal | 44 | 16-12-31 |
Tan Cheow Choon
PRN | Corporate Officer/Principal | - | - |
Todd Anthony
PRN | Corporate Officer/Principal | - | 09-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Brown
BRD | Director/Board Member | 59 | 22-07-14 |
A. Kazimi
CEO | Chief Executive Officer | 65 | 99-01-06 |
Ken Krogulski
BRD | Director/Board Member | 66 | 17-01-17 |
Joseph Galante
BRD | Director/Board Member | 74 | 18-09-18 |
Director/Board Member | 72 | 99-01-05 | |
James Jones
BRD | Director/Board Member | 76 | 09-12-31 |
Caroline Young
BRD | Director/Board Member | 49 | 16-06-09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,176,529 | 7,930,547 ( 55.94 %) | 0 | 55.94 % |
Company contact information
Cumberland Pharmaceuticals, Inc.
1600 West End Avenue Suite 1300
37203, Nashville
+
http://www.cumberlandpharma.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-1.77% | 24.1M | |
+19.62% | 43.78B | |
+20.44% | 21.89B | |
+10.86% | 14.45B | |
+13.07% | 13.63B | |
+37.46% | 11.49B | |
-8.59% | 6.85B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.06B |
- Stock Market
- Equities
- CPIX Stock
- Company Cumberland Pharmaceuticals Inc.